assessing stormwater management options to reduce event-based nutrient loading from urban non-point sources in the lake simcoe watershed

deadline: april 15, 2016

canadian water network’s canadian municipal water consortium is soliciting proposals to identify and assess opportunities to reduce event-based phosphorus/nutrient loading from urban non-point sources.

increased frequency and intensity of storms is becoming the norm and is driving the need for more effective water management options. current stormwater infrastructure is not typically designed to handle the scale of storms that are increasingly prevalent today. the effects of conveying large amounts of stormwater with no treatment and undersized infrastructure have led to negative impacts on receiving waters, including loading of chemical contaminants, pathogens and excess nutrients.

municipalities will benefit from a better understanding of nutrient loading that results from extreme storms as well as what options are available to reduce overall loadings. this information will help guide strategic investments by providing a better framework for the prioritization of best management practices (bmps).

this call is seeking proposals for an academically-led project of up to 14 months in duration with a maximum budget of $175,000 to assess the relative contributions of nutrients from urban non-point sources during extreme storms, and examine opportunities to reduce nutrient loading to the lake simcoe watershed through the identification and recommendation of effective bmps.

eligibility:

any researcher who is eligible to receive tri-council (nserc, cihr or sshrc) funding may apply to this call for proposals.

funding amount:

the project team may request up to a maximum of $175,000. this research call will be jointly funded by cwn and a third party granting body. the third party funding is currently pending approval, which is anticipated for early april, 2016. as such, the contract award for this project will be contingent upon cwn’s successful receipt of third party funding.

the joint programming initiative "a healthy diet for a healthy life" (jpi hdhl) has been established to coordinate research in the areas of food, diet, physical activity and health in order to achieve tangible societal and health impact and to strengthen european leadership and competitiveness in this field.

on 16th february 2016 the jpi hdhl together with the european commission has launched a new joint transnational call for research proposals: "biomarkers for nutrition and health (bionh)" using the era-net cofund instrument. the transnational call will focus on the identification and validation of biomarkers that are modulated by diet and that indicate a change in health status and/or the risk of developing diet-related diseases. biomarkers of physical activity may be considered alongside diet.

the jpi hdhl aims to create an international research network on bionh through the projects that will be funded in this era-hdhl cofunded call and the already funded projects of the ja bionh. this network of researchers, carrying out studies at pan-european and international level, will establish a critical mass of expertise necessary in this research area, allowing excellent science, sharing of standardised and innovative measures and research infrastructures, as well as training of young scientists in the field of bionh.

the deadline for the presentation of the pre-proposals is 19th april 2016 and the deadline for the full proposals is the 15th july 2016. the final decision on funding is expected by the end of september 2016.

the specific objectives of this funding opportunity are:

musculoskeletal (msk) rehabilitation:

• to create an interactive and coherent canadian network in msk rehabilitation that will tackle, in a coordinated manner, the clinical research challenges posed by a spectrum of chronic disabling msk disorders including, but not restricted to, arthritis, muscle and bone diseases, and injuries.
• to facilitate national and/or international collaboration, resource sharing, capacity building and dissemination in priority research areas.
• to advance research uptake, training, and knowledge translation in msk rehabilitation across multiple disciplines with a focus on expediting knowledge uptake to mobilize and build the research community.

myalgic encephalomyelopathy/chronic fatigue syndrome (me/cfs):

• to create an interactive and coherent canadian network in me/cfs that will tackle, in a coordinated manner, the clinical research challenges posed by this spectrum of chronic disabling disorders.
• to develop multiple population-based patient cohorts for translational research in me/cfs.
• to facilitate national collaboration, resource sharing, capacity building and dissemination in priority research areas.
• to provide the needed infrastructure around which to undertake therapeutic and diagnostic clinical studies in canada. in addition, this network will set the stage for potential future international collaborations.
• to advance research uptake, training, and knowledge translation in me/cfs across multiple disciplines with a focus on expediting knowledge uptake to mobilize and build the research community.

relevant research areas

the institute of musculoskeletal health and arthritis (imha) will provide funding for networks determined to be relevant to each of the following two priority areas:

• musculoskeletal rehabilitation
• me/cfs

the specific objectives of this funding opportunity are:

• supporting partnerships between communities affected by hiv in canada and researchers to facilitate the conduct of community-based research; and/or
• developing future applications for more comprehensive community-based research grants.

examples of activities that might be conducted under this funding opportunity (but are not restricted to) are:

• facilitation of dialogue between communities and researchers in order to establish research partnerships;
• workshops to design a research project and/or develop a proposal for a future cbr operating grant;
• planning and execution of pilot projects or feasibility studies to generate preliminary data, proof of concept; and/or
• development and / or validation of new inventions, tools, methodologies, protocols, theoretical models or frameworks.

through this eoi, ai-ees and sdtc are offering applicants a streamlined, harmonized model to access two pools of money through one application. collectively, there is $8 million available, with a maximum of $1,000,000 per project. the ratio for matching funds (67%) is more than an applicant could typically access through separate sdtc or ai-ees processes.

eligible projects:

• pre-commercial water related technologies that address: municipal water treatment; advanced steam assisted gravity drainage (sagd) water treatment; oil sands mine water treatment; flow-back and produced water from hydraulic fracturing; agriculture and irrigation; water distribution rehabilitation and repair.

• must be at the technology readiness level range of 4 to 7, which includes prototype development, field pilots, and commercial scale demonstration projects.

• are led by applicants both incorporated and operating in canada with less than 500 employees and less than $50 million in annual gross revenue.

• a consortium is required, which means the applicant must have at least one contractual non-related partner involved with the project.

• have a maximum project length of two years.

• project can demonstrates anywhere in canada, yet technology must be applicable and well-suited for deployment in alberta.

full details are available here – ai-ees or sdtc.

the eoi deadline is friday, april 15, 2016 at 3 p.m. mountain daylight time (5 p.m. eastern daylight time). applicants invited to submit a full project proposal will be notified by wednesday, may 25, 2016. final funding decisions will occur in early november 2016.

under this program, a university can be a partner – however a university would not qualify as the “consortium” partner under the definition used by sdtc (such a "partner" must be an entity further down a supply chain or an end user of a product).

the fiscal year 2016 (fy16) defense appropriations act provides $120 million (m) to the department of defense breast cancer research program (bcrp) to support innovative, high-impact breast cancer research to accelerate progress toward ending breast cancer.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency, research, development and acquisition (dha rda) directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy16 bcrp program announcements and general application instructions for the following award mechanisms are posted on grants.gov. 

applications submitted to the fy16 bcrp must address one or more of the following overarching challenges:

·         prevent breast cancer (primary prevention)

·         identify determinants of breast cancer initiation, risk, or susceptibility

·         distinguish deadly from indolent breast cancer

·         conquer the problems of overdiagnosis and overtreatment

·         identify what drives breast cancer growth; determine how to stop it

·         identify why some breast cancers become metastatic

·         determine why/how breast cancer cells lay dormant for years and then re-emerge (recurrence); determine how to prevent recurrence

·         revolutionize treatment regimens by replacing them with ones that are more effective and less toxic

·         eliminate the mortality associated with metastatic breast cancer

http://cdmrp.army.mil/funding/bcrp.shtml

breakthrough award – level 1 & 2  letter of intent due april 21, 2016, levels 3 & 4 preproposal due april 27, 2016

investigators at all academic levels (or equivalent)

senior postdoctoral fellows who do not meet the eligibility requirements of the breakthrough fellowship award are encouraged to apply under funding levels 1 and 2

supports promising research that has the potential to lead to or make breakthroughs in breast cancer.

potential impact of the research may be near-term or long-term, but it must be significant and go beyond an incremental advancement.

partnering pi option allows two pis, termed initiating and partnering pis, to collaborate on a single application.

four different funding levels, based on the scope of research, are available.  it is the responsibility of the pi to select the funding level that is most appropriate for the research proposed.  the funding level should be selected based on the scope of the research project, rather than the amount of the budget.

funding levels 1 and 2:

submission of a letter of intent is required prior to full application submission.

each pi may submit only one application as a pi or initiating pi.  there are no limitations on the number of applications for which an investigator may be named as a partnering pi.  however, applicants are discouraged from submitting as a partnering pi on multiple applications unless they are clearly unique, meaningful collaborations addressing distinct research questions.

additional funds are available for applications submitted under the partnering pi option.

clinical trials are not allowed.

funding levels 3 and 4:

clinical trials are allowed.

each pi may submit only one application as a pi or initiating pi.  there are no limitations on the number of applications for which an investigator may be named as a partnering pi.  however, applicants are discouraged from submitting as a partnering pi on multiple applications unless they are clearly unique, meaningful collaborations addressing distinct research questions.

pis must include two or more breast cancer advocates on their research team.

preproposal is required; application submission is by invitation only.

funding level 1:

maximum funding of $375,000 for direct costs (plus indirect costs)

maximum period of performance is 3 years

funding level 1 – partnering pi option:

maximum funding of $600,000 for direct costs (plus indirect costs)

maximum period of performance is 3 years

funding level 2:

maximum funding of $750,000 for direct costs (plus indirect costs)

maximum period of performance is 3 years

funding level 2 – partnering pi option:

maximum funding of $1 million (m) for direct costs (plus indirect costs)

maximum period of performance is 3 years

funding level 3:

maximum funding of $2.5m in direct costs (plus indirect costs)

maximum period of performance is 5 years

funding level 3 – partnering pi option:

maximum funding of $4m for direct costs (plus indirect costs)

maximum period of performance is 5 years

funding level 4 and funding level 4 – partnering pi option:

maximum funding of $10m for direct costs (plus indirect costs)

maximum period of performance is 5 years

breakthrough fellowship award (new!)- letter of intent due april 21, 2016

as of the application submission deadline, all eligible pis must have:

successfully completed the requirements for a doctoral or medical degree, and

been in the laboratory or clinical research setting in which the proposed research is to be performed for no more than 2 years, and

a total of less than 4 years experience in a postdoctoral fellowship or mentored clinical research training program (excludes any clinical residency or fellowship training)

mentor

must have breast cancer research experience, including current funding and recent publications

supports exceptionally talented, “best and brightest” recent doctoral or medical graduates in pursuit of promising research that has the potential to lead to or make breakthroughs in breast cancer.

potential impact of the research may be near-term or long-term, but it must be significant and go beyond an incremental advancement.

individualized training program and mentorship should prepare the pi for an independent career at the forefront of breast cancer research or patient care.

the pi is not required to have previous experience in breast cancer research.

maximum funding of $300,000 for direct costs (plus indirect costs)

maximum period of performance is 3 years

era of hope scholar award – letter of intent due april 21, 2016

independent, non-mentored investigators within 6 years of their last training position (e.g., postdoctoral fellowship, medical residency, clinical fellowship) as of the application submission deadline

supports exceptionally talented, creative early-career scientists who have demonstrated that they are the “best and brightest” in their fields.

pis should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.

pis should exhibit strong potential for leadership in the breast cancer community.

pis must include breast cancer advocates on their research team.

maximum funding of $2.5m for direct costs (plus indirect costs)

maximum period of performance is 5 years

innovator award – pre-application due april 27, 2016

associate professor or above (or equivalent).

supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field.

provides opportunity to pursue novel, visionary, high-risk ideas that will accelerate progress toward ending breast cancer.

pis must include breast cancer advocates on their research team.

preproposal is required; application submission is by invitation only.

maximum funding of $5m for direct costs (plus indirect costs).

maximum period of performance is 5 years.

distinguished investigator award – preproposal due april 27, 2016

assistant professor or above (or equivalent) and more than 6 years beyond the pi’s last training position as of the application submission deadline

seeks new paradigms in breast cancer research by supporting investigators who are established and recognized leaders in their field and who propose a fundamental shift or leap beyond their existing track record of research.

does not support continuation of or incremental change from the pi’s published line of research.

if the pi is an established breast cancer researcher, he/she must clearly articulate a motivation and commitment for proposing a fundamental shift in his/her research and must include at least one collaborator with breast cancer expertise.

pis must include two or more breast cancer advocates on their research team.

high-risk/high-reward projects pursuing innovative new paradigms are encouraged, but not required.

preproposal is required; application submission is by invitation only.

maximum funding of $3m for direct costs (plus indirect costs)

maximum period of performance is 5 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  for more information about the bcrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org

the trans-atlantic platform (t-ap) is launching the 2016 t-ap digging into data challenge to support research projects that use “big data” to address questions in the social sciences and humanities. in this context, “big data” refers to sets of data so large or complex that traditional processing applications are inadequate. these data sets can include sources such as texts, images, music, photographs, audio or audiovisual data.

the funding opportunity is open to international projects that consist of teams from at least three member countries, and must include partners from both sides of the atlantic. all projects must address any research question in humanities and/or social sciences disciplines by using large-scale, digital data analysis techniques, and show how these techniques can lead to new insights.

research partners will receive funding from their own national funding agencies for projects that can last for up to 36 months. canadian applicants may seek funding of up to c$275,000 for their section of an international project supported by at least two other countries.

the road safety research office in the ontario ministry of transportation (mto) would like to take this opportunity to invite you and/or other members of your organization to apply for the road safety research partnership program (rsrpp).

the purpose of this program is to fund research into the behavioural and social aspects of road user safety in order to identify the factors involved in motor vehicle collisions, suggest ways to reduce its impacts on individuals and society, and monitor the effectiveness of road safety initiatives. research funded through the rsrpp will support ontario’s efforts to improve road safety and keep the province among the safest jurisdictions in the world.

please refer to the attached guidelines, while keeping in the mind the following:

·         ontario hospitals, colleges, universities, and other public institutions are eligible for funding by the rsrpp. the principal investigator(s) must be a full- or part-time member of the faculty or an employee of the sponsoring institution.

·         eligible topics are in the behavioural and social sciences and relate to risk factors, preventive factors, and/or risk groups that are of road safety relevance in ontario. research proposals will only be considered if the proposed project could otherwise not be completed in-house (e.g., with a driving simulator, using human subjects, requiring primary data collection, requiring field work).

·         the total value of the research funding will be $150,000. in cases where more than one project is selected to be funded, the total available funds of $150,000 will be split between projects in a manner decided by mto.

·         the deadline for receipt of applications is april 15, 2016.

application form.